Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy

Affiliations

Yusuf Turkoz: Department of Biochemistry, Inonu University Turgut Ozal Medical Center, Malatya 44069, Turkey
Hamdi Er: Department of Ophthalmology, Inonu University Turgut Ozal Medical Center, Malatya 44069, Turkey
Mehmet Borazan: Department of Ophthalmology, Inonu University Turgut Ozal Medical Center, Malatya 44069, Turkey
Harun Yılmaz: Department of Ophthalmology, Inonu University Turgut Ozal Medical Center, Malatya 44069, Turkey
Bülent Mızrak: Department of Pathology, Inonu University Turgut Ozal Medical Center, Malatya 44069, Turkey
Hakan Parlakpınar: Department of Pharmacology, Inonu University Turgut Ozal Medical Center, Malatya 44069, Turkey
Yılmaz Çigremis: Department of Biology, Inonu University Turgut Ozal Medical Center, Malatya 44069, Turkey

Abstract

PURPOSE: To investigate whether caffeic acid phenethyl ester (CAPE) and cortisone prevent proliferative vitreoretinopathy (PVR).